United States Solid Tumors Drugs Market Research Report Forecast 2017 to 2022

April 2017 | 133 pages | ID: UB0AD9DECFFEN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The United States Solid Tumors Drugs Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Solid Tumors Drugs industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Solid Tumors Drugs market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

The Major players reported in the market include:
Hoffmann-La Roche
Novartis
Celgene
Johnson & Johnson
Pfizer
BMS
AbbVie
AbGenomics
ADC Therapeutics

United States Solid Tumors Drugs Market: Product Segment Analysis
Type 1
Type 2
Type 3

United States Solid Tumors Drugs Market: Application Segment Analysis
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 SOLID TUMORS DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Solid Tumors Drugs
1.2 Solid Tumors Drugs Market Segmentation by Type
  1.2.1 United States Production Market Share of Solid Tumors Drugs by Type in 2016
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Solid Tumors Drugs Market Segmentation by Application
  1.3.1 Solid Tumors Drugs Consumption Market Share by Application in 2016
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Solid Tumors Drugs (2011-2021)

CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON SOLID TUMORS DRUGS INDUSTRY

2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend

CHAPTER 3 UNITED STATES SOLID TUMORS DRUGS MARKET COMPETITION BY MANUFACTURERS

3.1 United States Solid Tumors Drugs Production and Share by Manufacturers (2015 and 2016)
3.2 United States Solid Tumors Drugs Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Solid Tumors Drugs Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Solid Tumors Drugs Manufacturing Base Distribution, Production Area and Product Type
3.5 Solid Tumors Drugs Market Competitive Situation and Trends
  3.5.1 Solid Tumors Drugs Market Concentration Rate
  3.5.2 Solid Tumors Drugs Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 UNITED STATES SOLID TUMORS DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

4.1 United States Solid Tumors Drugs Production and Market Share by Type (2012-2017)
4.2 United States Solid Tumors Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Solid Tumors Drugs Price by Type (2012-2017)
4.4 United States Solid Tumors Drugs Production Growth by Type (2012-2017)

CHAPTER 5 UNITED STATES SOLID TUMORS DRUGS MARKET ANALYSIS BY APPLICATION

5.1 United States Solid Tumors Drugs Consumption and Market Share by Application (2012-2017)
5.2 United States Solid Tumors Drugs Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
  5.3.1 Potential Applications
  5.3.2 Emerging Markets/Countries

CHAPTER 6 UNITED STATES SOLID TUMORS DRUGS MANUFACTURERS ANALYSIS

6.1 Hoffmann-La Roche
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Product Type, Application and Specification
  6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Business Overview
6.2 Novartis
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Product Type, Application and Specification
  6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Business Overview
6.3 Celgene
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Product Type, Application and Specification
  6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Business Overview
6.4 Johnson & Johnson
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Product Type, Application and Specification
  6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Business Overview
6.5 Pfizer
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Product Type, Application and Specification
  6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Business Overview
6.6 BMS
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.7 AbbVie
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Product Type, Application and Specification
  6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Business Overview
6.8 AbGenomics
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.9 ADC Therapeutics
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Product Type, Application and Specification
  6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Business Overview

CHAPTER 7 SOLID TUMORS DRUGS MANUFACTURING COST ANALYSIS

7.1 Solid Tumors Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Solid Tumors Drugs

CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Solid Tumors Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Solid Tumors Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

CHAPTER 11 UNITED STATES SOLID TUMORS DRUGS MARKET FORECAST (2017-2022)

11.1 United States Solid Tumors Drugs Production, Revenue Forecast (2017-2022)
11.2 United States Solid Tumors Drugs Production, Consumption Forecast by Regions (2017-2022)
11.3 United States Solid Tumors Drugs Production Forecast by Type (2017-2022)
11.4 United States Solid Tumors Drugs Consumption Forecast by Application (2017-2022)
11.5 Solid Tumors Drugs Price Forecast (2017-2022)

CHAPTER 12 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Solid Tumors Drugs
Table Classification of Solid Tumors Drugs
Figure United States Sales Market Share of Solid Tumors Drugs by Type in 2016
Table Application of Solid Tumors Drugs
Figure United States Sales Market Share of Solid Tumors Drugs by Application in 2016
Figure United States Solid Tumors Drugs Sales and Growth Rate (2011-2021)
Figure United States Solid Tumors Drugs Revenue and Growth Rate (2011-2021)
Table United States Solid Tumors Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Solid Tumors Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Solid Tumors Drugs Sales Share by Manufacturers
Figure 2016 Solid Tumors Drugs Sales Share by Manufacturers
Table United States Solid Tumors Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Solid Tumors Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Solid Tumors Drugs Revenue Share by Manufacturers
Table 2016 United States Solid Tumors Drugs Revenue Share by Manufacturers
Table United States Market Solid Tumors Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Solid Tumors Drugs Average Price of Key Manufacturers in 2015
Figure Solid Tumors Drugs Market Share of Top 3 Manufacturers
Figure Solid Tumors Drugs Market Share of Top 5 Manufacturers
Table United States Solid Tumors Drugs Sales by Type (2012-2017)
Table United States Solid Tumors Drugs Sales Share by Type (2012-2017)
Figure United States Solid Tumors Drugs Sales Market Share by Type in 2015
Table United States Solid Tumors Drugs Revenue and Market Share by Type (2012-2017)
Table United States Solid Tumors Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Solid Tumors Drugs by Type (2012-2017)
Table United States Solid Tumors Drugs Price by Type (2012-2017)
Figure United States Solid Tumors Drugs Sales Growth Rate by Type (2012-2017)
Table United States Solid Tumors Drugs Sales by Application (2012-2017)
Table United States Solid Tumors Drugs Sales Market Share by Application (2012-2017)
Figure United States Solid Tumors Drugs Sales Market Share by Application in 2016
Table United States Solid Tumors Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Solid Tumors Drugs Sales Growth Rate by Application (2012-2017)
Table Hoffmann-La Roche Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Hoffmann-La Roche Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Hoffmann-La Roche Solid Tumors Drugs Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Solid Tumors Drugs Market Share (2012-2017)
Table Celgene Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Celgene Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Celgene Solid Tumors Drugs Market Share (2012-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Johnson & Johnson Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Johnson & Johnson Solid Tumors Drugs Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Solid Tumors Drugs Market Share (2012-2017)
Table BMS Basic Information, Manufacturing Base, Production Area and Its Competitors
Table BMS Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table BMS Solid Tumors Drugs Market Share (2012-2017)
Table AbbVie Basic Information, Manufacturing Base, Production Area and Its Competitors
Table AbbVie Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table AbbVie Solid Tumors Drugs Market Share (2012-2017)
Table AbGenomics Basic Information, Manufacturing Base, Production Area and Its Competitors
Table AbGenomics Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table AbGenomics Solid Tumors Drugs Market Share (2012-2017)
Table ADC Therapeutics Basic Information, Manufacturing Base, Production Area and Its Competitors
Table ADC Therapeutics Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table ADC Therapeutics Solid Tumors Drugs Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Solid Tumors Drugs
Figure Manufacturing Process Analysis of Solid Tumors Drugs
Figure Solid Tumors Drugs Industrial Chain Analysis
Table Raw Materials Sources of Solid Tumors Drugs Major Manufacturers in 2016
Table Major Buyers of Solid Tumors Drugs
Table Distributors/Traders List
Figure United States Solid Tumors Drugs Production and Growth Rate Forecast (2017-2022)
Figure United States Solid Tumors Drugs Revenue and Growth Rate Forecast (2017-2022)
Table United States Solid Tumors Drugs Production Forecast by Type (2017-2022)
Table United States Solid Tumors Drugs Consumption Forecast by Application (2017-2022)

COMPANIES MENTIONED

Hoffmann-La Roche
Novartis
Celgene
Johnson & Johnson
Pfizer
BMS
AbbVie
AbGenomics
ADC Therapeutics
TG Therapeutics
Polaris Pharmaceuticals
Immunogen
CTI BioPharma
Chugai Pharmaceutical
NewLink Genetics